Pantoprazole DR

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-R-0010

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued a solicitation (Procurement Identifier: SPE2D2-26-R-0010) for the supply of Pantoprazole DR, a pharmaceutical preparation. This procurement falls under NAICS Code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on drugs and biologicals. The primary objective of this solicitation is to secure a reliable source of Pantoprazole DR specifically for Department of War (DoW) use, as clarified in Amendment 0001. This amendment also addresses previously missing information in the original solicitation, ensuring that all offerors are fully informed of the requirements and scope. The intended outcome is to support the medical and pharmaceutical needs of DoW personnel by ensuring timely and consistent access to this essential medication. Key requirements for this procurement include the manufacturing and supply of Pantoprazole DR in accordance with all applicable federal standards and regulations governing pharmaceutical products. Offerors are expected to demonstrate their capability to meet the quality, safety, and delivery standards set forth by the DLA Troop Support. The solicitation documents, including three attachments available via the provided SAM.gov link, contain detailed specifications and submission instructions. The contracting activity is managed by DLA Troop Support, a federal office within the Defense Logistics Agency. Interested parties may direct inquiries to the primary contact, Courtney Hunter ([email protected], 445-737-3585), or the secondary contact, Jason Wray ([email protected], 445-737-6304), for further clarification or assistance. This opportunity is currently active, with a posting date of January 7, 2026, and a response deadline of March 8, 2026. Contractors with experience in pharmaceutical preparation manufacturing and the capacity to fulfill federal requirements are encouraged to review the solicitation in detail and consider submitting a proposal. No specific set-aside requirements or special considerations are noted in the available information. For comprehensive details, including solicitation attachments and submission guidelines, interested vendors should refer to the official notice on SAM.gov at https://sam.gov/opp/b9c1800d112f42caa6bb245ae4022129/view.